Hui-Min Chen1, Jing-Yuan Fang. 1. GI Division, Shanghai Institute of Digestive Disease, Shanghai Jiao-Tong University School of Medicine-Renji Hospital, Shanghai, People's Republic of China.
Abstract
BACKGROUND AND AIMS: Hamartomatous polyposis syndromes are a heterogeneous group of disorders that are inherited in an autosomal dominant fashion. These syndromes only represent a small number of the inherited gastrointestinal cancer predisposition syndromes. However, many of these syndromes carry a substantial risk for developing colorectal cancer, as well as extra-colonic malignancy. MATERIALS AND METHODS: We searched for articles on inherited hamartomatous polyposis syndromes, including familial juvenile polyposis syndrome, Peutz-Jeghers syndrome, PTEN hamartoma tumor syndrome, multiple endocrine neoplasia syndrome 2B, hereditary mixed polyposis syndrome, Cronkhite-Canada syndrome, basal cell nevus syndrome, and neurofibromatosis 1, in PubMed, Embase, and Elsevier ScienceDirect. In this review, we briefly discuss the diagnosis and clinical features of these disorders and the molecular alterations responsible for these syndromes. RESULTS AND CONCLUSION: Given the clinical similarities of these hamartomatous syndromes and the autosomal dominant pattern of inheritance, it is sometimes difficult to differentiate hamartomatous polyps, especially with atypical presentation. The molecular analysis and diagnosis make it possible to identify the subtype of these syndromes. In addition, these tests raise an intriguing possibility that surveillance and early medical intervention will allow for the identification of at-risk patients and the reduction of morbidity and mortality.
BACKGROUND AND AIMS: Hamartomatous polyposis syndromes are a heterogeneous group of disorders that are inherited in an autosomal dominant fashion. These syndromes only represent a small number of the inherited gastrointestinal cancer predisposition syndromes. However, many of these syndromes carry a substantial risk for developing colorectal cancer, as well as extra-colonic malignancy. MATERIALS AND METHODS: We searched for articles on inherited hamartomatous polyposis syndromes, including familial juvenile polyposis syndrome, Peutz-Jeghers syndrome, PTEN hamartoma tumor syndrome, multiple endocrine neoplasia syndrome 2B, hereditary mixed polyposis syndrome, Cronkhite-Canada syndrome, basal cell nevus syndrome, and neurofibromatosis 1, in PubMed, Embase, and Elsevier ScienceDirect. In this review, we briefly discuss the diagnosis and clinical features of these disorders and the molecular alterations responsible for these syndromes. RESULTS AND CONCLUSION: Given the clinical similarities of these hamartomatous syndromes and the autosomal dominant pattern of inheritance, it is sometimes difficult to differentiate hamartomatous polyps, especially with atypical presentation. The molecular analysis and diagnosis make it possible to identify the subtype of these syndromes. In addition, these tests raise an intriguing possibility that surveillance and early medical intervention will allow for the identification of at-risk patients and the reduction of morbidity and mortality.
Authors: D J Marsh; J B Kum; K L Lunetta; M J Bennett; R J Gorlin; S F Ahmed; J Bodurtha; C Crowe; M A Curtis; M Dasouki; T Dunn; H Feit; M T Geraghty; J M Graham; S V Hodgson; A Hunter; B R Korf; D Manchester; S Miesfeldt; V A Murday; K L Nathanson; M Parisi; B Pober; C Romano; C Eng Journal: Hum Mol Genet Date: 1999-08 Impact factor: 6.150
Authors: Hiroyuki Miyoshi; Masayuki Nakau; Tomo-o Ishikawa; Michael F Seldin; Masanobu Oshima; Makoto M Taketo Journal: Cancer Res Date: 2002-04-15 Impact factor: 12.701
Authors: K L Woodford-Richens; A J Rowan; R Poulsom; S Bevan; R Salovaara; L A Aaltonen; R S Houlston; N A Wright; I P Tomlinson Journal: Am J Pathol Date: 2001-10 Impact factor: 4.307
Authors: H Hahn; C Wicking; P G Zaphiropoulous; M R Gailani; S Shanley; A Chidambaram; I Vorechovsky; E Holmberg; A B Unden; S Gillies; K Negus; I Smyth; C Pressman; D J Leffell; B Gerrard; A M Goldstein; M Dean; R Toftgard; G Chenevix-Trench; B Wainwright; A E Bale Journal: Cell Date: 1996-06-14 Impact factor: 41.582
Authors: Susan M Farrington; Albert Tenesa; Rebecca Barnetson; Alice Wiltshire; James Prendergast; Mary Porteous; Harry Campbell; Malcolm G Dunlop Journal: Am J Hum Genet Date: 2005-05-03 Impact factor: 11.025
Authors: Levent Ozsari; Merve Kutahyalioglu; Khaled M Elsayes; Rafael Andres Vicens; Kanishka Sircar; Tarek Jazaerly; Steven G Waguespack; Naifa L Busaidy; Maria E Cabanillas; Ramona Dadu; Mimi I Hu; Rena Vassilopoulou-Sellin; Camilo Jimenez; Jeffrey E Lee; Mouhammed Amir Habra Journal: Endocrine Date: 2015-07-25 Impact factor: 3.633